Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal Cultures

A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 26; no. 15; pp. 4118 - 4125
Main Authors Arttamangkul, Seksiri, Torrecilla, Maria, Kobayashi, Kazuto, Okano, Hideyuki, Williams, John T.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 12.04.2006
Subjects
Online AccessGet full text
ISSN0270-6474
1529-2401
1529-2401
DOI10.1523/JNEUROSCI.0303-06.2006

Cover

Abstract A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met] 5 enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.
AbstractList A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.
A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.
A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met] 5 enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.
A close relationship between desensitization and internalization of mu -opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus coeruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met] super(5)enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.
Author Torrecilla, Maria
Kobayashi, Kazuto
Arttamangkul, Seksiri
Williams, John T.
Okano, Hideyuki
Author_xml – sequence: 1
  givenname: Seksiri
  surname: Arttamangkul
  fullname: Arttamangkul, Seksiri
– sequence: 2
  givenname: Maria
  surname: Torrecilla
  fullname: Torrecilla, Maria
– sequence: 3
  givenname: Kazuto
  surname: Kobayashi
  fullname: Kobayashi, Kazuto
– sequence: 4
  givenname: Hideyuki
  surname: Okano
  fullname: Okano, Hideyuki
– sequence: 5
  givenname: John T.
  surname: Williams
  fullname: Williams, John T.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16611829$$D View this record in MEDLINE/PubMed
BookMark eNqFUsFu1DAUtFAR3RZ-ofKJW7Z24tgxQkho2cJWVRe19Gw5yUsxytqp7VCVb-Mb-Cac7rICDnCy5DcznnmeI3RgnQWETiiZ0zIvTs8vlzdX6-vFak4KUmSEz3NC-BM0S1OZ5YzQAzQjuSAZZ4IdoqMQvhBCBKHiGTqknFNa5XKG7q9h0F5H4yx2Hf7xPVsPxpkWX0EDQ3Qev4MANphovm1R2rZ4ZSN4q_vd3Su8tK27BevGsCcGbCz-6M1G-wd8CaN3iYAXYx9HD-E5etrpPsCL3XmMbs6WnxYfsov1-9Xi7UXWMFbEjJXQ1pRTWRPe0q7utGZkSiypqOqc67xralHSQkpSsapsdJXrFLPTopWgi-IYvdnqDmO9gbYBG73u1bD1pZw26s-JNZ_VrfuqOBdFJUUSeLkT8O5uhBDVxoQG-l5bSHEVFxVnpWT_BVJB6eQ0AU9-t7T38utTEuD1FtB4F4KHTjUmPi46OTS9okRNHVD7DqhpI4pwNXUg0flf9P0L_yb-BPHUuoc
CitedBy_id crossref_primary_10_1038_bjp_2008_100
crossref_primary_10_1074_jbc_M807535200
crossref_primary_10_1074_jbc_M806588200
crossref_primary_10_1016_j_neuropharm_2007_06_005
crossref_primary_10_1016_j_vascn_2021_107132
crossref_primary_10_1111_j_1471_4159_2007_04812_x
crossref_primary_10_1111_j_1476_5381_2011_01482_x
crossref_primary_10_4161_cc_10_21_18042
crossref_primary_10_1523_JNEUROSCI_4749_08_2009
crossref_primary_10_1016_j_tips_2006_09_006
crossref_primary_10_1523_JNEUROSCI_1310_16_2016
crossref_primary_10_1016_j_peptides_2007_09_002
crossref_primary_10_1371_journal_pone_0250011
crossref_primary_10_1002_ar_20860
crossref_primary_10_1152_jn_00563_2012
crossref_primary_10_1016_j_neuron_2018_04_021
crossref_primary_10_1111_bph_12709
crossref_primary_10_7554_eLife_34989
crossref_primary_10_1016_j_neuron_2012_09_022
crossref_primary_10_1021_acs_jmedchem_5b01664
crossref_primary_10_1371_journal_pone_0110230
crossref_primary_10_1124_mol_113_089003
crossref_primary_10_1152_ajpcell_00443_2018
crossref_primary_10_3389_fncir_2014_00062
crossref_primary_10_1016_j_brainres_2008_06_035
crossref_primary_10_1111_j_1471_4159_2008_05764_x
crossref_primary_10_1074_jbc_M806742200
crossref_primary_10_1523_JNEUROSCI_5999_10_2011
crossref_primary_10_1016_j_neuropharm_2015_04_033
crossref_primary_10_1124_mol_112_079350
crossref_primary_10_1016_j_neuron_2008_02_006
crossref_primary_10_1523_JNEUROSCI_1227_12_2012
crossref_primary_10_1111_bph_12706
crossref_primary_10_1111_bph_12703
crossref_primary_10_7554_eLife_68130
crossref_primary_10_1038_npp_2015_109
crossref_primary_10_1124_mol_112_078659
crossref_primary_10_1523_JNEUROSCI_1157_07_2007
crossref_primary_10_1124_jpet_106_113621
crossref_primary_10_1016_j_neuropharm_2022_109408
crossref_primary_10_1007_s10571_011_9755_5
crossref_primary_10_1016_j_neuroscience_2013_04_034
crossref_primary_10_1021_acs_jmedchem_7b01811
crossref_primary_10_1113_jphysiol_2014_275701
crossref_primary_10_1111_j_1476_5381_2011_01387_x
crossref_primary_10_1124_pr_112_005942
crossref_primary_10_1111_bph_13901
crossref_primary_10_1016_j_neuroscience_2006_06_021
crossref_primary_10_1523_JNEUROSCI_4136_11_2011
crossref_primary_10_1186_1756_6606_4_25
crossref_primary_10_1371_journal_pone_0188607
crossref_primary_10_1124_jpet_110_172643
crossref_primary_10_1124_mol_111_076208
crossref_primary_10_1124_mol_119_119321
crossref_primary_10_1124_mol_108_048512
crossref_primary_10_1016_j_pnpbp_2019_02_010
crossref_primary_10_1124_mol_119_119362
crossref_primary_10_1124_mol_107_042952
crossref_primary_10_1146_annurev_physiol_042022_015914
crossref_primary_10_1158_0008_5472_CAN_06_3803
crossref_primary_10_1002_jnr_21653
crossref_primary_10_1016_j_neuroscience_2010_04_003
crossref_primary_10_1016_j_neuropharm_2015_04_013
Cites_doi 10.1038/sj.bjp.0702693
10.1677/joe.1.05654
10.1016/S0896-6273(01)00517-7
10.1523/JNEUROSCI.22-13-05769.2002
10.1038/sj.bjp.0702922
10.1074/jbc.273.50.33174
10.1073/pnas.072075399
10.1038/sj.bjp.0705781
10.1016/S0026-895X(24)13072-6
10.1152/physrev.2001.81.1.299
10.1124/mol.105.013185
10.1523/JNEUROSCI.18-12-04588.1998
10.1523/JNEUROSCI.2499-04.2004
10.1124/mol.104.004994
10.1016/S0022-3565(24)38179-0
10.1523/JNEUROSCI.06-11-03229.1986
10.1074/jbc.M300525200
10.1074/jbc.M204136200
10.1124/mol.104.004747
10.1146/annurev.neuro.27.070203.144206
10.1210/me.2003-0066
10.1124/mol.58.6.1570
10.1016/S0031-6997(24)01478-9
10.1002/syn.10014
10.1016/S0959-4388(03)00069-2
10.1124/mol.52.1.136
10.1186/1475-925X-2-13
10.1124/jpet.102.040378
10.1016/0896-6273(94)90283-6
10.1124/mol.65.3.528
10.1523/JNEUROSCI.5045-04.2005
10.1046/j.1471-4159.2002.00972.x
10.1016/j.coph.2004.08.012
10.1074/jbc.271.32.19021
10.1073/pnas.111152398
10.1016/j.conb.2004.05.005
10.1523/JNEUROSCI.22-11-04328.2002
10.1016/S0896-6273(01)80032-5
ContentType Journal Article
Copyright Copyright © 2006 Society for Neuroscience 0270-6474/06/264118-08$15.00/0 2006
Copyright_xml – notice: Copyright © 2006 Society for Neuroscience 0270-6474/06/264118-08$15.00/0 2006
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
5PM
DOI 10.1523/JNEUROSCI.0303-06.2006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
Neurosciences Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 4125
ExternalDocumentID PMC6673897
16611829
10_1523_JNEUROSCI_0303_06_2006
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: T32 DA007262
– fundername: NIDA NIH HHS
  grantid: DA08163
– fundername: NIDA NIH HHS
  grantid: DA016627
GroupedDBID ---
-DZ
-~X
.55
.GJ
18M
1CY
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
ADXHL
AENEX
AETEA
AFCFT
AFFNX
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
MVM
OK1
P0W
P2P
QZG
R.V
RHI
RIG
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AFHIN
AIZTS
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7TK
7X8
5PM
ID FETCH-LOGICAL-c443t-45edb1619b06d1fbfaa4003039178b26a2fcb75139908485ca82a007fa7d9ea33
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 14:12:43 EDT 2025
Fri Sep 05 11:06:40 EDT 2025
Thu Sep 04 18:35:58 EDT 2025
Wed Feb 19 02:35:01 EST 2025
Tue Jul 01 02:58:35 EDT 2025
Thu Apr 24 23:03:57 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c443t-45edb1619b06d1fbfaa4003039178b26a2fcb75139908485ca82a007fa7d9ea33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jneurosci.org/content/jneuro/26/15/4118.full.pdf
PMID 16611829
PQID 17117513
PQPubID 23462
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6673897
proquest_miscellaneous_67864594
proquest_miscellaneous_17117513
pubmed_primary_16611829
crossref_citationtrail_10_1523_JNEUROSCI_0303_06_2006
crossref_primary_10_1523_JNEUROSCI_0303_06_2006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-04-12
PublicationDateYYYYMMDD 2006-04-12
PublicationDate_xml – month: 04
  year: 2006
  text: 2006-04-12
  day: 12
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2006
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References (2023041303174552000_26.15.4118.22) (1994); 12
(2023041303174552000_26.15.4118.38) (1984); 26
(2023041303174552000_26.15.4118.40) (2001); 81
2023041303174552000_26.15.4118.21
2023041303174552000_26.15.4118.41
2023041303174552000_26.15.4118.20
(2023041303174552000_26.15.4118.10) (1999); 127
2023041303174552000_26.15.4118.28
2023041303174552000_26.15.4118.3
2023041303174552000_26.15.4118.25
2023041303174552000_26.15.4118.4
2023041303174552000_26.15.4118.5
2023041303174552000_26.15.4118.23
2023041303174552000_26.15.4118.6
2023041303174552000_26.15.4118.24
2023041303174552000_26.15.4118.7
2023041303174552000_26.15.4118.8
2023041303174552000_26.15.4118.9
(2023041303174552000_26.15.4118.34) (1998); 18
(2023041303174552000_26.15.4118.39) (1987); 243
(2023041303174552000_26.15.4118.26) (1998); 54
(2023041303174552000_26.15.4118.2) (2000); 58
(2023041303174552000_26.15.4118.35) (2002); 22
(2023041303174552000_26.15.4118.1) (2002); 22
2023041303174552000_26.15.4118.32
2023041303174552000_26.15.4118.11
2023041303174552000_26.15.4118.33
2023041303174552000_26.15.4118.30
2023041303174552000_26.15.4118.18
2023041303174552000_26.15.4118.19
(2023041303174552000_26.15.4118.27) (1999); 289
2023041303174552000_26.15.4118.17
2023041303174552000_26.15.4118.14
(2023041303174552000_26.15.4118.29) (1986); 6
2023041303174552000_26.15.4118.36
2023041303174552000_26.15.4118.15
(2023041303174552000_26.15.4118.31) (1995); 47
2023041303174552000_26.15.4118.37
2023041303174552000_26.15.4118.12
2023041303174552000_26.15.4118.13
(2023041303174552000_26.15.4118.16) (2001); 53
References_xml – volume: 127
  start-page: 1533
  year: (1999)
  ident: 2023041303174552000_26.15.4118.10
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0702693
– ident: 2023041303174552000_26.15.4118.20
  doi: 10.1677/joe.1.05654
– volume: 243
  start-page: 397
  year: (1987)
  ident: 2023041303174552000_26.15.4118.39
  publication-title: J Pharmacol Exp Ther
– ident: 2023041303174552000_26.15.4118.17
  doi: 10.1016/S0896-6273(01)00517-7
– volume: 22
  start-page: 5769
  year: (2002)
  ident: 2023041303174552000_26.15.4118.1
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-13-05769.2002
– ident: 2023041303174552000_26.15.4118.11
  doi: 10.1038/sj.bjp.0702922
– ident: 2023041303174552000_26.15.4118.5
  doi: 10.1074/jbc.273.50.33174
– ident: 2023041303174552000_26.15.4118.7
  doi: 10.1073/pnas.072075399
– ident: 2023041303174552000_26.15.4118.12
  doi: 10.1038/sj.bjp.0705781
– volume: 54
  start-page: 704
  year: (1998)
  ident: 2023041303174552000_26.15.4118.26
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(24)13072-6
– volume: 81
  start-page: 299
  year: (2001)
  ident: 2023041303174552000_26.15.4118.40
  publication-title: Physiol Rev
  doi: 10.1152/physrev.2001.81.1.299
– ident: 2023041303174552000_26.15.4118.15
  doi: 10.1124/mol.105.013185
– volume: 18
  start-page: 4588
  year: (1998)
  ident: 2023041303174552000_26.15.4118.34
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.18-12-04588.1998
– ident: 2023041303174552000_26.15.4118.14
  doi: 10.1523/JNEUROSCI.2499-04.2004
– ident: 2023041303174552000_26.15.4118.25
  doi: 10.1124/mol.104.004994
– volume: 289
  start-page: 607
  year: (1999)
  ident: 2023041303174552000_26.15.4118.27
  publication-title: J Pharm Exp Ther
  doi: 10.1016/S0022-3565(24)38179-0
– volume: 6
  start-page: 3229
  year: (1986)
  ident: 2023041303174552000_26.15.4118.29
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.06-11-03229.1986
– ident: 2023041303174552000_26.15.4118.8
  doi: 10.1074/jbc.M300525200
– ident: 2023041303174552000_26.15.4118.41
  doi: 10.1074/jbc.M204136200
– ident: 2023041303174552000_26.15.4118.4
  doi: 10.1124/mol.104.004747
– ident: 2023041303174552000_26.15.4118.18
  doi: 10.1146/annurev.neuro.27.070203.144206
– ident: 2023041303174552000_26.15.4118.24
  doi: 10.1210/me.2003-0066
– volume: 58
  start-page: 1570
  year: (2000)
  ident: 2023041303174552000_26.15.4118.2
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.58.6.1570
– volume: 53
  start-page: 1
  year: (2001)
  ident: 2023041303174552000_26.15.4118.16
  publication-title: Pharmacol Rev
  doi: 10.1016/S0031-6997(24)01478-9
– ident: 2023041303174552000_26.15.4118.28
  doi: 10.1002/syn.10014
– ident: 2023041303174552000_26.15.4118.36
  doi: 10.1016/S0959-4388(03)00069-2
– ident: 2023041303174552000_26.15.4118.21
  doi: 10.1124/mol.52.1.136
– ident: 2023041303174552000_26.15.4118.32
  doi: 10.1186/1475-925X-2-13
– ident: 2023041303174552000_26.15.4118.6
  doi: 10.1124/jpet.102.040378
– volume: 12
  start-page: 433
  year: (1994)
  ident: 2023041303174552000_26.15.4118.22
  publication-title: Neuron
  doi: 10.1016/0896-6273(94)90283-6
– volume: 26
  start-page: 489
  year: (1984)
  ident: 2023041303174552000_26.15.4118.38
  publication-title: Mol Pharmacol
– ident: 2023041303174552000_26.15.4118.9
  doi: 10.1124/mol.65.3.528
– ident: 2023041303174552000_26.15.4118.19
  doi: 10.1523/JNEUROSCI.5045-04.2005
– ident: 2023041303174552000_26.15.4118.30
  doi: 10.1046/j.1471-4159.2002.00972.x
– ident: 2023041303174552000_26.15.4118.3
  doi: 10.1016/j.coph.2004.08.012
– volume: 47
  start-page: 666
  year: (1995)
  ident: 2023041303174552000_26.15.4118.31
  publication-title: Mol Pharmacol
– ident: 2023041303174552000_26.15.4118.23
  doi: 10.1074/jbc.271.32.19021
– ident: 2023041303174552000_26.15.4118.33
  doi: 10.1073/pnas.111152398
– ident: 2023041303174552000_26.15.4118.13
  doi: 10.1016/j.conb.2004.05.005
– volume: 22
  start-page: 4328
  year: (2002)
  ident: 2023041303174552000_26.15.4118.35
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-11-04328.2002
– ident: 2023041303174552000_26.15.4118.37
  doi: 10.1016/S0896-6273(01)80032-5
SSID ssj0007017
Score 2.124178
Snippet A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of...
A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of...
A close relationship between desensitization and internalization of mu -opioid receptors (MORs) has been proposed based on differential actions of series of...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 4118
SubjectTerms Animals
Brain - physiology
Cell Culture Techniques
Genes, Reporter
Green Fluorescent Proteins - analysis
Green Fluorescent Proteins - genetics
Locus Coeruleus - physiology
Mice
Mice, Transgenic
Neurons - cytology
Neurons - physiology
Receptors, Opioid, mu - physiology
Title Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal Cultures
URI https://www.ncbi.nlm.nih.gov/pubmed/16611829
https://www.proquest.com/docview/17117513
https://www.proquest.com/docview/67864594
https://pubmed.ncbi.nlm.nih.gov/PMC6673897
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9MwENZkyoULA5RHeOpAuTBO_ZAtm1vJhAntUGDSzvTmkWW5mFC7k9jDpL-N39DfxOrhR9LyKBdPolhK5P2yu5J2v0XoVZDZjPPQszjngUWE8K0ozIjFoyT1KBgYN5GJwh8Pg-kx2T_xTwaDy17UUl0lI35xbV7J_0gV2kCuMkv2BpJtB4UGeA3yhStIGK7_JOOZ0Mzd2ufbGU923o2tT-d5mcukQxmwUi5AoyxlkHplEi5NALDmfjZtcltgUqSlIWxtuqpQ2c-GjkKxeEjXVZNwmtDDbx3Yeq5tjySzh6iqYmesOJ3Xatd5JubLfJF3u9wLybMBoDQZRHlrLw5A5axkzScd_XFRV2W7NTxnqnT4m2meilU9zzc3MSRbYk_XuRRWsUQX7BkJo4tddfjj9JW1Tq9vQOn3VC9xjCIX5q1OqL5iInxFVbF_KCMlZ-MPI9Bysr6FOoXqjGITCLBhK9sIRrl2gpHidpxYjhPbQawZ4G-5NAhkRY2DLx17PbVVBeh2siZjHcbZvf73rDtLV1ZAm4G8Pc_o6C66Y-SO9zQ-76GBKO6j7b2CVeXZCr_GKshYnd5sox8dZHGZ4cufBq64wRzegCsGuOINuL7FHVjbjkucF9iAFTdgxQ1YH6Dj95Oj8dQytT8sTohXWcQXaQKrkSixg9TJkowxIg2SFzk0TNyAuRlPqA_rl0hWhPA5C10GTzhjNI0E87yHaKsoC_EYYUEYtZmdMZGA-wwdSMhSzqE589IsDIbIbx5yzA0xvqzP8j3-s5CHaLftd66n99ceLxsZxqDF5dEcKwQ8q9ihkjLX8X5_BziVkveJDNEjLfPuO8HFdkI3GiK6hob2Bskgv_5JkX9VTPKq5m9En9x4Jk_R7e5v_AxtVYtaPAfvvEpeKMj_AtIb6VE
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Separation+of+%CE%BC-Opioid+Receptor+Desensitization+and+Internalization%3A+Endogenous+Receptors+in+Primary+Neuronal+Cultures&rft.jtitle=The+Journal+of+neuroscience&rft.au=Arttamangkul%2C+Seksiri&rft.au=Torrecilla%2C+Maria&rft.au=Kobayashi%2C+Kazuto&rft.au=Okano%2C+Hideyuki&rft.date=2006-04-12&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=26&rft.issue=15&rft.spage=4118&rft.epage=4125&rft_id=info:doi/10.1523%2FJNEUROSCI.0303-06.2006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1523_JNEUROSCI_0303_06_2006
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon